Moderate Evidence
Research Overview
Alixorexton Research for Excessive Daytime Sleepiness
An overview of research and source records on Alixorexton in the context of excessive daytime sleepiness.
Research Summary
Phase 2 data showed dose-dependent improvements in objective wakefulness measures. Patients demonstrated significant increases in MWT sleep latency and improved subjective sleepiness scores on the Epworth Sleepiness Scale compared to placebo.
References
Open a reference to inspect its source record. A citation does not establish a clinical benefit.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.